SEC Form 4 · accession 0001179110-19-001700
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Young Kwon
Officer — SVP, Chief Business Officer
Period of report
Feb 7, 2019
Accepted (ET)
Feb 11, 2019 · 4:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF3 | Feb 7, 2019 | M | 1,409 | — | A | 112,450 | D | |
| Common Stock | Feb 8, 2019 | S | 494 | $11.52 | D | 111,956 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF3,F4 | — | Feb 7, 2019 | M | 1,409 | D | — | — | Common Stock | 1,409 | 11,276 | D |
Explanation of responses
- F1Shares received pursuant to settlement of Restricted Stock Units that were granted on February 7, 2017.
- F2This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- F3Restricted Stock Units convert into common stock on a one-for-one basis.
- F4Subject to certain criteria, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years.